EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 68 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $227,000 | -5.8% | 3,806 | +24.4% | 0.21% | -3.7% |
| Q2 2017 | $241,000 | -4.7% | 3,060 | +0.3% | 0.22% | -12.6% |
| Q1 2017 | $253,000 | -18.4% | 3,050 | -21.9% | 0.25% | -24.5% |
| Q4 2016 | $310,000 | +2.6% | 3,905 | -9.4% | 0.33% | +9.7% |
| Q3 2016 | $302,000 | +38.5% | 4,310 | -20.0% | 0.30% | +150.4% |
| Q1 2016 | $218,000 | -54.1% | 5,388 | +0.6% | 0.12% | -49.1% |
| Q4 2015 | $475,000 | +19.6% | 5,358 | 0.0% | 0.23% | +9.3% |
| Q3 2015 | $397,000 | -2.9% | 5,358 | +6.1% | 0.21% | +17.6% |
| Q2 2015 | $409,000 | -18.2% | 5,052 | -57.6% | 0.18% | -17.6% |
| Q1 2015 | $500,000 | – | 11,925 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |